19 — 22 May 2015 
Grand Hyatt Shanghai, China 
IBC 
LIFE SCIENCES 
4th ANNUAL 5th ANNUAL 6th ANNUAL 
3 Co-Located Events 
1 Joint Networking & Exhibition Area 
15+ Networking Opportunities 
4+ Days of Expert Knowledge Sharing 
280+ Attendees across the 
Biopharma Value Chain 
Biopharma Decision Makers 
Under 1 Roof 
Past Sponsors & Exhibitors 
Produced by: 
Media Partners: 
is now part of the Sartorius Stedim Biotech Group 
www.biopharmaproduction.com 
International Marketing Partner: 
Associations: 
Life 
Sciences
4th ANNUAL 5th ANNUAL 6th ANNUAL 
As the BioPharma industry grows in China and the Asian region, we invite you to 
be a part of this tremendous growth & development opportunities! 
IBC’s Biopharma Development & Production Week in China is THE meeting place 
for biopharma industry professionals and scientists to get the highest quality and 
practical information that will enable them to develop competitive advantages and 
advance their capabilities in developing and manufacturing cell lines, biosimilars, 
biobetters, vaccines or novel biologics. 
Top Reasons Why You Should Participate: 
Establish Business Partnerships with Chinese/Asian drug developers and contract 
manufacturers 
Learn technical & practical know how from experiences on the ground in Asia 
Showcase your cutting edge solutions in front of key China/Asian Biopharma 
decision makers 
Thursday 21 May 2015 
Main Conference Day Two 
19 — 22 May 2015 
Grand Hyatt Shanghai, China 
Bringing Together 
the Biopharma 
Industry & 
Its Stakeholders! 
PROGRAMME AT A GLANCE 
Tuesday 19 May 2015 
Pre-Conference Workshops 
Wednesday 20 May 2015 
Main Conference Day One 
Registration Opens & Morning Coffee 
Welcome to all 
delegates to the BDP 
Week Conferences 
Opening Remarks from IBC Asia & Speed Networking 
Shared Biopharma Visionary Keynote Sessions 
SFDA Keynote: China’s Evolving Biologic & 
Biosimilars Regulations 
Panel Discusion: 
C-Level Global Biopharma Industry Outlook Trends 
Biopharma Technology & Solution Showcase 
Cell Line 
Development & 
Engineering 
Biomanufacturing 
Facilities: 
Projects & Design 
Biomanufacturing 
Operations: 
Process & Quality 
Biosimilars 
Morning Refreshment Break 
Get to know your 
industry peers 
and exchange 
business cards! 
Showcase your 
cutting edge 
solutions! 
Cell Line Development & 
Engineering 
Demonstrate 
your thought 
leadership! 
Biomanufacturing Biosimilars 
Breakout into 4 
tracks packed with 
quality content 
Cell Line 
Development & 
Engineering 
Get your business 
cards ready! 
Morning Refreshment Break 
Biomanufacturing 
Facilities: 
Projects & Design 
Biomanufacturing 
Operations: 
Process & Quality 
Biosimilars 
Networking Luncheon – VIP Lunch Tables 
Visit the shared exhibition 
during the refreshment & 
lunch breaks 
Cell Line Development & 
Engineering 
Biomanufacturing Biosimilars 
Networking Luncheon – VIP Lunch Tables 
Cell Line 
Development & 
Engineering 
Biomanufacturing 
Facilities: 
Projects & Design 
Biomanufacturing 
Operations: 
Process & Quality 
Have a close intimate 
lunch with industry 
leaders! 
Biosimilars 
Friday 22 May 2015 
Biopharma Development & Production Roundtables 
Site Tour to a Biomanufacturing Facility 
Post-Conference Workshops 
Networking Cocktail 
Dinner 
End of Conference 
Host the networking 
cocktail/dinner & be 
seen in the industry! 
Time to brainstorm, 
question & 
challenge today’s 
hot issues 
Don’t Just Take Our Word For It Here’s What Attendees Have to Say! 
“Valuable, world-class and professionally-organized, this 
conference was among the very best I’ve ever attended.” 
Peter Fuhrman, Chairman & Chief Executive Officer, China First Capital 
“It is a great opportunity to learn biomanufacturing in China.” 
Kang Li, Head of Biologics, Beigene 
“Very insightful conference with a broad range of issues 
discussed and excellent speakers.” 
Ramesh Rajentheran, Managing Director, Head – Asian Healthcare, 
Investment Banking, Barclays 
“The IBC Asia event was well organized and thought out. It 
attracted thought leaders, not just from Asia, but from all over 
the world to share their knowledge and experience on 
addressing current biopharma industry challenges.” 
Jeremy M. Caudill, Vice President Global Business Development, 
Samsung Biologics 
“It was a well organised conference with relevant speakers and 
panel discussions. It was a good place for networking as well. 
Would definitely like to be part of future conferences organised 
by IBC.” 
Rajeev Soni, Associate Vice President, R&D, Biocon 
Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com
4th ANNUAL 5th ANNUAL 6th ANNUAL 
GEOGRAPHY 
■ China 50% 
■ Rest of North Asia 15% 
■ Southeast Asia & India 10% 
■ Europe 10% 
■ US 10% 
■ Rest of the World 5% 
Who You Will Meet at BDP 
Chairman/Chief Executive Officer 
Chief Operations Officer 
Chief Scientific Officer 
Chief Technology Officer 
Chief Marketing Officer 
Senior Vice President 
Vice President Biologics 
Vice President Biosimilars 
Vice President of R&D 
Vice President of Manufacturing 
Vice President of Facilities 
Head of Cell Line Development 
Principal Scientist 
Head Process Development 
General Manager 
Director 
Business Development 
Sales & Marketing Manager 
A 
Abec Inc 
Actis Capital Partners Pte Ltd 
AlphaMab 
AstraZeneca 
Austar 
AutekBio 
Avesthagen 
B 
Bao Chuan Biopharmaceutical 
Technology (Shanghai) Co Ltd/ 
Dragonfly Sciences 
Barclays Capital Asia Ltd 
Baxter (China) Investment Co Ltd 
BD Biosciences 
Becton Dickinson Holdings Pte Ltd 
BeiGene Beijing Co Ltd 
Beijing Mabworks Biotech Co Ltd 
Beijing Shenogen Biomedical Co 
Ltd 
Beijing Yizhuang Biomedical Park 
Bio Thera Solutions 
Biodiscover 
Biopharmaceuticals Australia 
Bioprocessing Technology 
Institute 
Bio-Reach Co Ltd 
Boehringer Ingelheim 
Biopharmaceuticals GmbH 
Boehringer Ingelheim Shanghai 
Pharmaceiticals Co Ltd 
Boehringer-Ingelheim Pharma 
GmbH & Co KG 
Boston Oncology 
C Cadila Pharmaceuticals Ltd 
Campbell Alliance 
CB Consultancy 
Chang Cun Sheng Jin Nuo 
Biomedical Co Ltd 
Charter Medical SAS 
China First Capital 
CK Life Sciences International 
Commissioning Agents 
International Inc 
Complya Asia Co Ltd 
Covance Pharmaceutical R&D 
(Shangha) Co Ltd 
Covington and Burling L L P 
CPGJ Pharma 
CRB Consulting Engineers Inc 
Cytovance Biologics 
D 
DCB 
Destiny Bio Co Ltd 
Development Center for 
Biotechnology 
Dingfu Biotarget 
Dow Corning China Holding Co 
Ltd 
Dr Reddy's Laboratories Ltd 
E 
Elanco (A Division of Eli Lilly (Asia) 
Inc) 
Envirotainer Pte Ltd 
Eurofins Panlabs Taiwan Ltd 
F 
F Hoffmann-La Roche Ltd 
FeF Chemicals 
FountainVest Investment Advisory 
Shanghai Co Ltd 
Fresenius Kabi 
Fresenius Kabi Taiwan Ltd 
GG 
allus BioPharmaceuticals NJ LLC 
Gan & Lee Pharmaceuticals 
GE HC Life Sciences China 
GE Healthcare 
GE Healthcare Medical System 
Trade Development (Shanghai) 
Limited 
Genemen Biotech (Chengdu) Co 
Ltd 
Genor BioPharma 
GenScript 
Genzyme Korea Co Ltd 
Genzyme Singapore Pte Ltd 
GlaxoSmithKline (China) R&D Co 
Ltd 
Gmax BioPharm LLC 
Gmax BioPharm LLC 
Guangzhou Standard Pharma Ltd 
Guilin Sanjin Pharmaceutical Co 
Ltd 
H 
HEC Pharma Co. Ltd 
Hefei Tianmai Biotechnology 
Development Co Ltd 
Henlius Biopharmaceuticals Inc 
Hisun Pharma (Hangzhou) Co Ltd 
HitchinRock Advisors Pte Ltd 
Hongda Biological Pharmaceutical 
Company 
Horizon Biopharm 
Hua Yue Enterprise Holdings Ltd 
Hua Yue Reacon Scientific Co Ltd 
HuaBo Biopharm (Shanghai) Co 
Ltd 
Hualan Biological Chongqing Co 
Ltd 
INDUSTRY 
■ Pharmaceuticals/Biotech 50% 
■ CMOs 15% 
■ CROs 15% 
■ Technology & Solution Providers 10% 
■ Finance/Law 10% 
II 
mmuOn Therapeutics 
Indian Immunologicals Ltd 
Innogene Kalbiotech Pte Ltd 
Innovent Biologics Inc 
Institute of Biotechnology, 
Academy of Military Medical 
Services 
Intas Biopharmaceuticals Ltd 
inVentiv Clinical Trial Recruitment 
Solutions (iCTRS) 
inVentiv Health Clinical 
inVentiv Health Shanghai Inc Ltd 
J 
Janssen China 
Janssen Pharmaceutical 
JHL Biotech Inc 
Jiang Su Heng Rui Medicine Co 
Ltd 
Jiangsu Hanbon Science & 
Technology Co Ltd 
Jiangsu Pacific-Meinuoke Bio- 
Pharmaceutical Co Ltd 
Jiangsu T-mab Biopharma Co Ltd 
Jianshun Biosciences Co Ltd 
Jinan University 
Jones Day 
KK 
albe International Pte Ltd 
KPCB China 
L Leo Pharma 
Liaoning Chenda Biotechnology 
Co Ltd 
Lingmed Limited 
Livzon MabPharm Inc 
LIVZON Pharmaceutical Group Inc 
Lonza Biologics Tuas Pte Ltd 
Lupin Limited 
Luye Pharmaceutical Co Ltd 
MM 
abSpace Biosciences Co Ltd 
Merck Chemicals (Shanghai) Co 
Ltd 
Merck Millipore 
Merck Millipore SAS 
Merck Pte Ltd 
Merck Serono Co Ltd 
Mergermarket 
Mitsubishi Corporation 
Molecular Devices 
Molecular Devices Beijing 
MSD China Holding Co Ltd 
MSD R&D (China) Co Ltd 
Mycenax Biotech Inc 
Mylan Laboratories Limited 
N 
Nankai University 
Neuclone 
NNE Pharmaplan 
Novartis Global Sourcing Office 
China 
Novartis Pharma Co Ltd 
Novartis Vaccine (China) 
Novasep Asia 
Novo Nordisk Research Center 
China 
Novozymes South Asia Pvt Ltd 
P Pall Filter (Beijing) Co Ltd 
Pfizer 
Pfizer Corporation Hong Kong Ltd 
Pfizer Global R&D Co Ltd 
Pfizer Investment Co Ltd 
PPD 
PPD China 
PRA 
PRA International 
Proteomics International Pty Ltd 
PT Kalbe Farma Tbk 
Q 
Qilu Pharmaceutical 
Quintiles Research (India) Pvt Ltd 
R 
ReqMed Co Ltd 
S 
SAFC Biosciences 
Saint-Gobain Performance Plastics 
(Shanghai) Co Ltd 
Samsung BioLogics 
Sanape LLC 
Sanofi 
Sanofi (China) Investment Co Ltd 
Shanghai Biomabs 
Pharmaceuticals Co Ltd 
Shanghai Chempartner Co Ltd 
Shanghai CP Guojian 
Pharmaceutical Co Ltd 
Shanghai GB Investment 
Management Consulting Co Ltd 
Shanghai Henlius Biotech Co Ltd 
Shanghai Institute of Biologival 
Products Co Ltd 
Shanghai JMT-Bio Inc 
Shanghai Roche Pharmaceuticals 
Ltd 
Shanghai Tasly Pharmaceutical Co 
Ltd 
Shanghai United Cell 
Biotechnology Co Ltd 
Shanghai Zerun Biotech Co Ltd 
Shanghai†Hengrui†Pharmaceuti 
cals† Co Ltd 
ShangPharma Corp 
Shen Zhen DongYangGuang 
Industry Co Ltd 
Shenyang Sunshine 
Pharmaceutical Co Ltd 
3SBio Inc 
Sigma-Aldrich Co Ltd 
Simcere Pharmaceutical Group 
Sinovac Biotech Co Ltd 
Strides Arcolab Ltd 
Swedish Orphan Biovitrum AB 
T Takeda California Inc 
TAP Biosystems 
Tasly Holding Group Academy 
Tasly Holding Group Co Ltd 
Thomson Reuters 
Tianjin Qiankunyuan Biotech 
TOT Biopharm Co Ltd 
TTY Biopharm Co Ltd 
U 
UCB Asia Pacific 
UCB Pharmaceutical China 
United Laboratories Inc 
University of Barcelona 
University of Manchester 
University of Tubingen 
W Walter Biotech Consultancy 
Walvax Group 
Western Biologists 
Wuhan Humanwell Healthcare 
(Group) Co Ltd 
WuXi AppTec Inc 
WuXi Pra Clinical Research 
Shanghai Co Ltd 
WuxiApptec (Shanghai) Co Ltd 
X 
Xiamen University 
Y Yichang Changjiang 
Pharmaceutical Co Ltd 
Z Zebra Biologics Inc 
Zhejiang Hisun Pharmaceutical Co 
Ltd 
Zhejiang Teruisi Pharmaceutical 
Inc 
Zydus Biologics 
19 — 22 May 2015 
Grand Hyatt Shanghai, China 
Companies that Attended Biopharma Development & Production in 2014 include: 
Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com
4th ANNUAL 5th ANNUAL 6th ANNUAL 
19 — 22 May 2015 
Grand Hyatt Shanghai, China 
Partnership Opportunities Now Available! 
Strategic Branding Networking Functions Onsite Branding Product Showcase 
Profile your organisation as an 
industry leader and leverage on 
our integrated marketing 
campaign to extend your 
marketing reach. 
• Platinum Sponsor 
• Gold Sponsor 
• Silver Sponsor 
Engage your captive audience at 
an exclusive event hosted by 
your organisation. 
• Hospitality Suite Sponsor 
• Press / VIP Room Sponsor 
• Lunch Sponsor 
• Breakfast Sponsor 
• Refreshment breaks Sponsor 
• Cocktail Sponsor 
Reinforce your branding and 
seize the opportunity to enhance 
your brand visibility at the event. 
• Onsite Banners and Stands 
• Conference Bag Sponsor 
• Lanyard Sponsor 
• Corporate Gift Sponsor 
• Documentation Sponsor 
• Cyber Café Sponsor 
Showcase your products and 
solutions and engage your 
targeted audience through the 
exhibition stands or table 
displays 
We would be glad to discuss customised options that would suit your budgets and help achieve your desired marketing objectives. 
Floor Plan 2015 
Booked Booked Booked 
1.5m 
1.5m 
1.5m 
1.5m 
1.5m 
Grand Hyatt Shanghai 
Grand Ballroom 1 & 2 
19 18 
17 16 15 14 13 12 
23 24 25 
26 27 28 29 
Reserved Reserved 
20 
21 
1 2 
3 4 5 6 
11 
10 
9 
8 
7 
6.57m 6.30m 
Booked 
Booked 
Booked Booked 
Reserved Reserved Reserved Reserved 
Entrance 
Entrance 
For more information about how you can leverage on our events to optimize your marketing budget 
and reach your target audience, please contact: Ms. Yvonne Leong at Tel: +65 6508 2489 
Email: Yvonne.leong@ibcasia.com.sg | Website: www.biopharmaproduction.com 
22 
Booked Booked 
Booked Reserved Reserved Booked 
Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com

Biopharma Production and Development China 2015

  • 1.
    19 — 22May 2015 Grand Hyatt Shanghai, China IBC LIFE SCIENCES 4th ANNUAL 5th ANNUAL 6th ANNUAL 3 Co-Located Events 1 Joint Networking & Exhibition Area 15+ Networking Opportunities 4+ Days of Expert Knowledge Sharing 280+ Attendees across the Biopharma Value Chain Biopharma Decision Makers Under 1 Roof Past Sponsors & Exhibitors Produced by: Media Partners: is now part of the Sartorius Stedim Biotech Group www.biopharmaproduction.com International Marketing Partner: Associations: Life Sciences
  • 2.
    4th ANNUAL 5thANNUAL 6th ANNUAL As the BioPharma industry grows in China and the Asian region, we invite you to be a part of this tremendous growth & development opportunities! IBC’s Biopharma Development & Production Week in China is THE meeting place for biopharma industry professionals and scientists to get the highest quality and practical information that will enable them to develop competitive advantages and advance their capabilities in developing and manufacturing cell lines, biosimilars, biobetters, vaccines or novel biologics. Top Reasons Why You Should Participate: Establish Business Partnerships with Chinese/Asian drug developers and contract manufacturers Learn technical & practical know how from experiences on the ground in Asia Showcase your cutting edge solutions in front of key China/Asian Biopharma decision makers Thursday 21 May 2015 Main Conference Day Two 19 — 22 May 2015 Grand Hyatt Shanghai, China Bringing Together the Biopharma Industry & Its Stakeholders! PROGRAMME AT A GLANCE Tuesday 19 May 2015 Pre-Conference Workshops Wednesday 20 May 2015 Main Conference Day One Registration Opens & Morning Coffee Welcome to all delegates to the BDP Week Conferences Opening Remarks from IBC Asia & Speed Networking Shared Biopharma Visionary Keynote Sessions SFDA Keynote: China’s Evolving Biologic & Biosimilars Regulations Panel Discusion: C-Level Global Biopharma Industry Outlook Trends Biopharma Technology & Solution Showcase Cell Line Development & Engineering Biomanufacturing Facilities: Projects & Design Biomanufacturing Operations: Process & Quality Biosimilars Morning Refreshment Break Get to know your industry peers and exchange business cards! Showcase your cutting edge solutions! Cell Line Development & Engineering Demonstrate your thought leadership! Biomanufacturing Biosimilars Breakout into 4 tracks packed with quality content Cell Line Development & Engineering Get your business cards ready! Morning Refreshment Break Biomanufacturing Facilities: Projects & Design Biomanufacturing Operations: Process & Quality Biosimilars Networking Luncheon – VIP Lunch Tables Visit the shared exhibition during the refreshment & lunch breaks Cell Line Development & Engineering Biomanufacturing Biosimilars Networking Luncheon – VIP Lunch Tables Cell Line Development & Engineering Biomanufacturing Facilities: Projects & Design Biomanufacturing Operations: Process & Quality Have a close intimate lunch with industry leaders! Biosimilars Friday 22 May 2015 Biopharma Development & Production Roundtables Site Tour to a Biomanufacturing Facility Post-Conference Workshops Networking Cocktail Dinner End of Conference Host the networking cocktail/dinner & be seen in the industry! Time to brainstorm, question & challenge today’s hot issues Don’t Just Take Our Word For It Here’s What Attendees Have to Say! “Valuable, world-class and professionally-organized, this conference was among the very best I’ve ever attended.” Peter Fuhrman, Chairman & Chief Executive Officer, China First Capital “It is a great opportunity to learn biomanufacturing in China.” Kang Li, Head of Biologics, Beigene “Very insightful conference with a broad range of issues discussed and excellent speakers.” Ramesh Rajentheran, Managing Director, Head – Asian Healthcare, Investment Banking, Barclays “The IBC Asia event was well organized and thought out. It attracted thought leaders, not just from Asia, but from all over the world to share their knowledge and experience on addressing current biopharma industry challenges.” Jeremy M. Caudill, Vice President Global Business Development, Samsung Biologics “It was a well organised conference with relevant speakers and panel discussions. It was a good place for networking as well. Would definitely like to be part of future conferences organised by IBC.” Rajeev Soni, Associate Vice President, R&D, Biocon Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com
  • 3.
    4th ANNUAL 5thANNUAL 6th ANNUAL GEOGRAPHY ■ China 50% ■ Rest of North Asia 15% ■ Southeast Asia & India 10% ■ Europe 10% ■ US 10% ■ Rest of the World 5% Who You Will Meet at BDP Chairman/Chief Executive Officer Chief Operations Officer Chief Scientific Officer Chief Technology Officer Chief Marketing Officer Senior Vice President Vice President Biologics Vice President Biosimilars Vice President of R&D Vice President of Manufacturing Vice President of Facilities Head of Cell Line Development Principal Scientist Head Process Development General Manager Director Business Development Sales & Marketing Manager A Abec Inc Actis Capital Partners Pte Ltd AlphaMab AstraZeneca Austar AutekBio Avesthagen B Bao Chuan Biopharmaceutical Technology (Shanghai) Co Ltd/ Dragonfly Sciences Barclays Capital Asia Ltd Baxter (China) Investment Co Ltd BD Biosciences Becton Dickinson Holdings Pte Ltd BeiGene Beijing Co Ltd Beijing Mabworks Biotech Co Ltd Beijing Shenogen Biomedical Co Ltd Beijing Yizhuang Biomedical Park Bio Thera Solutions Biodiscover Biopharmaceuticals Australia Bioprocessing Technology Institute Bio-Reach Co Ltd Boehringer Ingelheim Biopharmaceuticals GmbH Boehringer Ingelheim Shanghai Pharmaceiticals Co Ltd Boehringer-Ingelheim Pharma GmbH & Co KG Boston Oncology C Cadila Pharmaceuticals Ltd Campbell Alliance CB Consultancy Chang Cun Sheng Jin Nuo Biomedical Co Ltd Charter Medical SAS China First Capital CK Life Sciences International Commissioning Agents International Inc Complya Asia Co Ltd Covance Pharmaceutical R&D (Shangha) Co Ltd Covington and Burling L L P CPGJ Pharma CRB Consulting Engineers Inc Cytovance Biologics D DCB Destiny Bio Co Ltd Development Center for Biotechnology Dingfu Biotarget Dow Corning China Holding Co Ltd Dr Reddy's Laboratories Ltd E Elanco (A Division of Eli Lilly (Asia) Inc) Envirotainer Pte Ltd Eurofins Panlabs Taiwan Ltd F F Hoffmann-La Roche Ltd FeF Chemicals FountainVest Investment Advisory Shanghai Co Ltd Fresenius Kabi Fresenius Kabi Taiwan Ltd GG allus BioPharmaceuticals NJ LLC Gan & Lee Pharmaceuticals GE HC Life Sciences China GE Healthcare GE Healthcare Medical System Trade Development (Shanghai) Limited Genemen Biotech (Chengdu) Co Ltd Genor BioPharma GenScript Genzyme Korea Co Ltd Genzyme Singapore Pte Ltd GlaxoSmithKline (China) R&D Co Ltd Gmax BioPharm LLC Gmax BioPharm LLC Guangzhou Standard Pharma Ltd Guilin Sanjin Pharmaceutical Co Ltd H HEC Pharma Co. Ltd Hefei Tianmai Biotechnology Development Co Ltd Henlius Biopharmaceuticals Inc Hisun Pharma (Hangzhou) Co Ltd HitchinRock Advisors Pte Ltd Hongda Biological Pharmaceutical Company Horizon Biopharm Hua Yue Enterprise Holdings Ltd Hua Yue Reacon Scientific Co Ltd HuaBo Biopharm (Shanghai) Co Ltd Hualan Biological Chongqing Co Ltd INDUSTRY ■ Pharmaceuticals/Biotech 50% ■ CMOs 15% ■ CROs 15% ■ Technology & Solution Providers 10% ■ Finance/Law 10% II mmuOn Therapeutics Indian Immunologicals Ltd Innogene Kalbiotech Pte Ltd Innovent Biologics Inc Institute of Biotechnology, Academy of Military Medical Services Intas Biopharmaceuticals Ltd inVentiv Clinical Trial Recruitment Solutions (iCTRS) inVentiv Health Clinical inVentiv Health Shanghai Inc Ltd J Janssen China Janssen Pharmaceutical JHL Biotech Inc Jiang Su Heng Rui Medicine Co Ltd Jiangsu Hanbon Science & Technology Co Ltd Jiangsu Pacific-Meinuoke Bio- Pharmaceutical Co Ltd Jiangsu T-mab Biopharma Co Ltd Jianshun Biosciences Co Ltd Jinan University Jones Day KK albe International Pte Ltd KPCB China L Leo Pharma Liaoning Chenda Biotechnology Co Ltd Lingmed Limited Livzon MabPharm Inc LIVZON Pharmaceutical Group Inc Lonza Biologics Tuas Pte Ltd Lupin Limited Luye Pharmaceutical Co Ltd MM abSpace Biosciences Co Ltd Merck Chemicals (Shanghai) Co Ltd Merck Millipore Merck Millipore SAS Merck Pte Ltd Merck Serono Co Ltd Mergermarket Mitsubishi Corporation Molecular Devices Molecular Devices Beijing MSD China Holding Co Ltd MSD R&D (China) Co Ltd Mycenax Biotech Inc Mylan Laboratories Limited N Nankai University Neuclone NNE Pharmaplan Novartis Global Sourcing Office China Novartis Pharma Co Ltd Novartis Vaccine (China) Novasep Asia Novo Nordisk Research Center China Novozymes South Asia Pvt Ltd P Pall Filter (Beijing) Co Ltd Pfizer Pfizer Corporation Hong Kong Ltd Pfizer Global R&D Co Ltd Pfizer Investment Co Ltd PPD PPD China PRA PRA International Proteomics International Pty Ltd PT Kalbe Farma Tbk Q Qilu Pharmaceutical Quintiles Research (India) Pvt Ltd R ReqMed Co Ltd S SAFC Biosciences Saint-Gobain Performance Plastics (Shanghai) Co Ltd Samsung BioLogics Sanape LLC Sanofi Sanofi (China) Investment Co Ltd Shanghai Biomabs Pharmaceuticals Co Ltd Shanghai Chempartner Co Ltd Shanghai CP Guojian Pharmaceutical Co Ltd Shanghai GB Investment Management Consulting Co Ltd Shanghai Henlius Biotech Co Ltd Shanghai Institute of Biologival Products Co Ltd Shanghai JMT-Bio Inc Shanghai Roche Pharmaceuticals Ltd Shanghai Tasly Pharmaceutical Co Ltd Shanghai United Cell Biotechnology Co Ltd Shanghai Zerun Biotech Co Ltd Shanghai†Hengrui†Pharmaceuti cals† Co Ltd ShangPharma Corp Shen Zhen DongYangGuang Industry Co Ltd Shenyang Sunshine Pharmaceutical Co Ltd 3SBio Inc Sigma-Aldrich Co Ltd Simcere Pharmaceutical Group Sinovac Biotech Co Ltd Strides Arcolab Ltd Swedish Orphan Biovitrum AB T Takeda California Inc TAP Biosystems Tasly Holding Group Academy Tasly Holding Group Co Ltd Thomson Reuters Tianjin Qiankunyuan Biotech TOT Biopharm Co Ltd TTY Biopharm Co Ltd U UCB Asia Pacific UCB Pharmaceutical China United Laboratories Inc University of Barcelona University of Manchester University of Tubingen W Walter Biotech Consultancy Walvax Group Western Biologists Wuhan Humanwell Healthcare (Group) Co Ltd WuXi AppTec Inc WuXi Pra Clinical Research Shanghai Co Ltd WuxiApptec (Shanghai) Co Ltd X Xiamen University Y Yichang Changjiang Pharmaceutical Co Ltd Z Zebra Biologics Inc Zhejiang Hisun Pharmaceutical Co Ltd Zhejiang Teruisi Pharmaceutical Inc Zydus Biologics 19 — 22 May 2015 Grand Hyatt Shanghai, China Companies that Attended Biopharma Development & Production in 2014 include: Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com
  • 4.
    4th ANNUAL 5thANNUAL 6th ANNUAL 19 — 22 May 2015 Grand Hyatt Shanghai, China Partnership Opportunities Now Available! Strategic Branding Networking Functions Onsite Branding Product Showcase Profile your organisation as an industry leader and leverage on our integrated marketing campaign to extend your marketing reach. • Platinum Sponsor • Gold Sponsor • Silver Sponsor Engage your captive audience at an exclusive event hosted by your organisation. • Hospitality Suite Sponsor • Press / VIP Room Sponsor • Lunch Sponsor • Breakfast Sponsor • Refreshment breaks Sponsor • Cocktail Sponsor Reinforce your branding and seize the opportunity to enhance your brand visibility at the event. • Onsite Banners and Stands • Conference Bag Sponsor • Lanyard Sponsor • Corporate Gift Sponsor • Documentation Sponsor • Cyber Café Sponsor Showcase your products and solutions and engage your targeted audience through the exhibition stands or table displays We would be glad to discuss customised options that would suit your budgets and help achieve your desired marketing objectives. Floor Plan 2015 Booked Booked Booked 1.5m 1.5m 1.5m 1.5m 1.5m Grand Hyatt Shanghai Grand Ballroom 1 & 2 19 18 17 16 15 14 13 12 23 24 25 26 27 28 29 Reserved Reserved 20 21 1 2 3 4 5 6 11 10 9 8 7 6.57m 6.30m Booked Booked Booked Booked Reserved Reserved Reserved Reserved Entrance Entrance For more information about how you can leverage on our events to optimize your marketing budget and reach your target audience, please contact: Ms. Yvonne Leong at Tel: +65 6508 2489 Email: Yvonne.leong@ibcasia.com.sg | Website: www.biopharmaproduction.com 22 Booked Booked Booked Reserved Reserved Booked Contact: Yvonne Leong +65 6508 2489 yvonne.leong@ibcasia.com.sg www.biopharmaproduction.com